Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin
- PMID: 7860740
- PMCID: PMC295516
- DOI: 10.1172/JCI117700
Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin
Abstract
Increased binding of the lectin peanut agglutinin is a common feature in epithelial malignancy and hyperplasia. This may have considerable functional importance in the intestine by allowing interaction between the epithelium and mitogenic lectins of dietary or microbial origin. Peanut agglutinin binds the disaccharide Thomsen-Friedenreich (TF, T or core 1) blood group antigen, Gal beta (1-3) GalNAc alpha-, but is not totally specific for this site. Consequently, there has been controversy about the presence of this structure in colon cancer; studies with anti-TF monoclonal antibodies have failed to detect it. We have examined the presence of TF antigen in colonic mucus glycoprotein (mucin) using endo-alpha-N-acetylgalactosaminidase (O-Glycanase), which specifically catalyzes the hydrolysis of TF antigen from glycoconjugates. Samples of adenocarcinoma, inflammatory bowel disease (ulcerative colitis), and normal mucin were treated with O-glycanase, the liberated disaccharide was separated from the glycoprotein and analyzed using dual CarboPac PA-100 column high performance anion-exchange chromatography coupled with pulsed amperometric detection. O-Glycanase treatment released increased amounts of TF antigen from both colonic adenocarcinoma (8.0 +/- 3.9 ng/micrograms protein, n = 11; P < 0.0001 ANOVA) and ulcerative colitis mucin (3.3 +/- 0.3 ng/micrograms protein, n = 5; P = 0.04) compared with mucin samples from histologically normal mucosa distant from carcinoma (1.5 +/- 1.1 ng/micrograms protein, n = 9). However, after mild acid treatment to remove sialic acids and fucose, releasable TF antigen was increased in all nine of these histologically normal mucin samples (5.5 +/- 2.6 ng/micrograms protein, P < 0.0002). We conclude that TF antigen is an oncofetal antigen which is expressed in colon cancer, but is concealed by further glycosylation (sialylation and/or fucosylation) in the normal colonic mucosa.
Similar articles
-
Reversible inhibition of proliferation of epithelial cell lines by Agaricus bisporus (edible mushroom) lectin.Cancer Res. 1993 Oct 1;53(19):4627-32. Cancer Res. 1993. PMID: 8402638
-
Human urinary bladder carcinoma glycoconjugates expressing T-(Gal beta(1-3)GalNAc alpha 1-O-R) and T-like antigens: a comparative study using peanut agglutinin and poly- and monoclonal antibodies.Cancer Res. 1992 Sep 15;52(18):5030-6. Cancer Res. 1992. PMID: 1516058
-
Studies on the Thomsen-Friedenreich antigen in human colon with the lectin Amaranthin. Normal and neoplastic epithelium express only cryptic T antigen.Lab Invest. 1992 Feb;66(2):175-86. Lab Invest. 1992. PMID: 1370965
-
Lectin-epithelial interactions in the human colon.Biochem Soc Trans. 2008 Dec;36(Pt 6):1482-6. doi: 10.1042/BST0361482. Biochem Soc Trans. 2008. PMID: 19021580 Review.
-
The Thomsen-Friedenreich (TF) antigen: a critical review on the structural, biosynthetic and histochemical aspects of a pancarcinoma-associated antigen.Histol Histopathol. 1997 Jan;12(1):263-81. Histol Histopathol. 1997. PMID: 9046061 Review.
Cited by
-
Altered glycosylation in inflammatory bowel disease: a possible role in cancer development.Glycoconj J. 2001 Nov-Dec;18(11-12):851-8. doi: 10.1023/a:1022240107040. Glycoconj J. 2001. PMID: 12820718 Review.
-
C1GALT1 in health and disease.Oncol Lett. 2021 Aug;22(2):589. doi: 10.3892/ol.2021.12850. Epub 2021 Jun 6. Oncol Lett. 2021. PMID: 34149900 Free PMC article. Review.
-
Finding the sweet spot: glycosylation mediated regulation of intestinal inflammation.Mucosal Immunol. 2022 Feb;15(2):211-222. doi: 10.1038/s41385-021-00466-8. Epub 2021 Nov 15. Mucosal Immunol. 2022. PMID: 34782709 Free PMC article. Review.
-
Mucin glycosylation is altered by pro-inflammatory signaling in pancreatic-cancer cells.J Proteome Res. 2009 Apr;8(4):1876-86. doi: 10.1021/pr8008379. J Proteome Res. 2009. PMID: 19714813 Free PMC article.
-
O-linked protein glycosylation structure and function.Glycoconj J. 1996 Feb;13(1):19-26. doi: 10.1007/BF01049675. Glycoconj J. 1996. PMID: 8785483 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous